Interní Med. 2010; 12(9): 404-406
Latest trends in pharmacotherapy of COPD
- Klinika pneumologie a hrudní chirurgie FN Na Bulovce, 3. LF UK a IPVZ Praha
Chronic obstructive pulmonary disease (COPD) has become a treatable condition; however, it remains a very serious global problem.
Approximately 600 million people suffer from the disease. In Europe, the prevalence ranges from 4 % to 10 % in persons over 40 years
of age. However, the condition is largely underdiagnosed and the number of patients is expected to be two-fold and the prevalence has
been steadily increasing, particularly among women. Modern pharmacotherapy can affect numerous parameters, improves the quality
of life of patients, alleviates the symptoms, reduces exacerbations and appears to positively affect the disease-related mortality.
Keywords: COPD, pharmacotherapy, tiotropium, fixed combination, indacaterol, roflumilast
Published: October 1, 2010 Show citation
References
- Vondra V, Malý M, Švandová E. Rozborilová E. Úmrtnost na chronickou obstrukční plicní nemoc v ČR a SR v letech 1999-2003. Medicína po promoci 2005; 6: 80-88.
- Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated December 2009; www.goldcopd.com.
- Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 2007; 370: 797-799.
Go to original source... 
Go to PubMed... - Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Eng J Med 2008? 359: 1543-1554. Go to original source... Go to PubMed...
- Kašák V. Chronická obstrukční plicní nemoc. Praha, Maxdorf 2006; 187.
- Barnes PJ. Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase. Lancet 2004; 363: 731-733. Go to original source... Go to PubMed...
- Szafranski W, Culkier A, Ramirez A, et al. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J 2003; 21: 74-81. Go to original source... Go to PubMed...
- Calverley PM, Boonsawat W, Cseke Z, et al. Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. Eur Respir J 2003; 22: 912-919. Go to original source... Go to PubMed...
- Calverley P, Pauwels R, Vestbo J, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2003; 361: 449-456. Go to original source... Go to PubMed...